Reduction of chemotherapy-induced anorexia, nausea, and emesis through a structured nursing intervention: a cluster-randomized multicenter trial
Authors:
- Patrick JahnPJPatrick Jahn
- Petra RenzPRPetra Renz
- Joerg StukenkemperJSJoerg Stukenkemper
- Katrin BookKBKatrin Book
- Oliver KussOKOliver Kuss
- Karin JordanKJKarin Jordan
- Ingrid HornIHIngrid Horn
- Anette Thoke-ColbergATAnette Thoke-Colberg
- Hans-Joachim SchmollHSHans-Joachim Schmoll
- Margarete LandenbergerMLMargarete Landenberger
- 23 July 2009
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 17 (12) , 1543-1552
Abstract
The purpose of this present study was to evaluate Self-care Improvement through Oncology Nursing (SCION) program to reduce distressing anorexia, nausea, and emesis (ANE) in cancer patients undergoing chemotherapy. Two hundred eight patients receiving chemotherapy with moderate to high emetogenic potential participated in a cluster randomized trial on 14 wards in two German university hospitals. Additionally to standard antiemetic treatment, patients from the intervention wards received the SCION program consisting of four modules: advisory consultation, optimizing emesis prophylaxis, nutrition counseling, and relaxation. Patients from the control group received standard antiemetic treatment and standard care. Primary outcome was the group difference in ANE intensity assessed by Common Terminology Criteria for adverse events (CTCAE). The SCION program did not result in a significant difference in the incidence of ANE symptoms as compared to standard care: mean difference on CTCAE scale was 0.24 pts (95%CI, −1.17 to 1.66 pts; P = 0.733). No difference could be found regarding patients’ knowledge of side effects, self-care interventions, and agency. Health-related quality of life was significantly better for patients in the control group (mean difference 10.2 pts; 95%CI, 1.9 to 18.5; P = 0.017). Contrary to our expectations, the groups did not differ in ANE intensity caused by the overall low acute or delayed symptom intensity. Symptom hierarchy in cancer patients alters and challenges nursing interventions targeting the patients’ self-care strategies.Keywords
This publication has 29 references indexed in Scilit:
- Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 2008
- Prevention of chemotherapy- and radiotherapy-induced emesis: results of the 2004 Perugia International Antiemetic Consensus ConferenceAnnals of Oncology, 2005
- Anticipatory nausea and vomitingSupportive Care in Cancer, 2004
- Patient expectation is a strong predictor of severe nausea after chemotherapyCancer, 2004
- Incidence of chemotherapy‐induced nausea and emesis after modern antiemeticsCancer, 2004
- The Effect of Education in Managing Side Effects in Women Receiving Chemotherapy for Treatment of Breast CancerOncology Nursing Forum, 2004
- Treatment of Nausea and Emesis During Cancer ChemotherapyJournal of Pain and Symptom Management, 2002
- A Canadian Survey of Cancer Patients’ ExperiencesJournal of Pain and Symptom Management, 1998
- Effect of postchemotherapy nausea and vomiting on health-related quality of lifeSupportive Care in Cancer, 1997
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993